Treatment of Oligometastatic GI Cancers
Authors:
- 1 January 2024
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in American Society of Clinical Oncology Educational Book
- Vol. 44 (1) , e430152
Abstract
Oligometastatic state is believed to potentially represent a transitional stage between early, locoregional state disease and widely metastatic disease. Historically, locoregional approaches, particularly in advanced colorectal cancers, have demonstrated efficacy in select patients with limited burden of metastatic disease. Recent strides in systemic therapies, including biomarker-based treatments and immunotherapy, alongside innovations in surgical techniques and novel locoregional approaches such as stereotactic radiotherapy and ablation, have ushered in a new era of therapeutic possibilities across all oligometastatic GI cancers. Despite these advancements, there remains a significant gap in high-quality prospective evidence guiding patient selection and treatment decisions across various disease types. Ongoing clinical trials are anticipated to provide crucial insights into oligometastatic states, fostering the refinement of disease-specific oligometastatic state definitions and treatment algorithms. This article reviews existing data on the management of oligometastatic GI cancer, summarizes current state of knowledge for each disease state, and provides updates on ongoing studies in this space.Keywords
This publication has 87 references indexed in Scilit:
- Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung MetastasesCardioVascular and Interventional Radiology, 2012
- Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trialBMC Cancer, 2012
- Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional AnalysisAnnals of Surgical Oncology, 2010
- Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancerColorectal Disease, 2009
- Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric CancerJournal of Korean Medical Science, 2009
- Expanding Criteria for Resectability of Colorectal Liver MetastasesThe Oncologist, 2008
- Phase II Study of Cisplatin and 5-Fluorouracil with Concurrent Radiotherapy in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516)Japanese Journal of Clinical Oncology, 2004
- Surgical treatment of colorectal metastases to the liverCA: A Cancer Journal for Clinicians, 1995